XyloCor Therapeutics

Updated: September 01, 2025

CEO Albert Gianchetti

Country: USA | Funding: $107.1M (+)

Website: https://xylocor.com/

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.

Competitors